louisiana tirzepatide class action glp-1 intestinal paralysis semaglutide gastrointestinal obstruction law firm in lawyer glp-1 gastric obstruction attorney louisiana Ozempic GLP-1 Lawsuit & Gastroparesis Ozempic Lawsuit louisiana glp-1 stomach paralysis class Mounjaro Lawsuit - July 2026

Participants who started at 2.5 mg and advanced every four weeks reported better medication adherence and greater weight loss sustainability at 12 months

The results are often cumulative, and regular infusions may be needed to sustain the benefits over time

Treatment Duration: Weight loss continues throughout 16-20 months of treatment

That level of confidence is rare in the industry and signals that the company believes its protocols and support structure actually deliver results

GHRH analogues such as CJC-1295 and Tesamorelin mimic growth-hormone-releasing hormone, while Ipamorelin is a selective secretagogue that acts on the ghrelin/GH-secretagogue receptor